A new approach to treating intractable epilepsy [ 2016 - 2019 ]

Research Grant

Researchers: Prof Adam Mccluskey (Principal investigator) ,  A/Pr Nigel Jones ,  Prof Phillip Robinson

Brief description Epilepsy is one of the most common chronic neurological disorders; it affects 1% of the world’s population, yet about 1 in 3 patients fail to achieve seizure control with current drugs. We will improve the properties of small molecules (drugs) that specifically target the GTPase activity of the enzyme dynamin, to reduce seizure effect in the brain by a novel mechanism. We will optimize and pre-clinically test these future chemical entities as potential anti-epileptic drugs.

Funding Amount $AUD 1,231,803.90

Funding Scheme Project Grants

Notes Standard Project Grant